MARKET

DYAI

DYAI

Dyadic Intl Inc Del
NASDAQ
0.9698
+0.0398
+4.28%
After Hours: 0.9700 +0.0002 +0.02% 18:09 01/07 EST
OPEN
0.9312
PREV CLOSE
0.9300
HIGH
0.9900
LOW
0.9300
VOLUME
22.31K
TURNOVER
--
52 WEEK HIGH
2.143
52 WEEK LOW
0.7110
MARKET CAP
35.09M
P/E (TTM)
-4.0903
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DYAI last week (1229-0102)?
Weekly Report · 3d ago
Dyadic International Amends Convertible Notes, Extends Maturity Timeline
TipRanks · 12/29/2025 21:38
Dyadic International Extends Convertible Note Maturity and Sets New Conversion Price
Reuters · 12/29/2025 21:01
Weekly Report: what happened at DYAI last week (1222-1226)?
Weekly Report · 12/29/2025 09:03
Weekly Report: what happened at DYAI last week (1215-1219)?
Weekly Report · 12/22/2025 09:03
Dyadic International, Fermbox Bio expand strategic collaboration
TipRanks · 12/17/2025 12:26
Dyadic Applied BioSolutions Expands Collaboration With Fermbox Bio To Manufacture And Commercialize Animal-Free Proteins And Enzymes
Benzinga · 12/17/2025 12:23
Dyadic International Expands Collaboration With Fermbox Bio to Accelerate Animal-Free Protein Commercialization
Reuters · 12/17/2025 12:20
More
About DYAI
Dyadic International, Inc. is a biotechnology company focused on the large-scale manufacture of proteins for use in human and animal vaccines and therapeutics and for use in non-pharmaceutical applications including food, nutrition, and wellness. The Company's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica, which the Company named C1. The Compny’s lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The Company has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Webull offers Dyadic International Inc stock information, including NASDAQ: DYAI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DYAI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DYAI stock methods without spending real money on the virtual paper trading platform.